Intimation of confirmation of appointment of directors.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals Ltd (formerly Trimurthi Limited) informed the stock exchange that shareholders at an Extra Ordinary General Meeting on May 9, 2025 confirmed the appointment of two directors. Mr. Lakshman Samala (DIN: 10783725) was confirmed as a Non-Executive Independent Director for a five-year term effective February 12, 2025. Mr. Jivamohan Divakar Valluri (DIN: 09218013) was confirmed as a Non-Executive Non-Independent Director effective April 12, 2025. Both directors have stated they are not related to any existing director, KMP, or promoter of the company, and neither has been debarred by SEBI or any other authority from holding a director position. Mr. Samala brings a PhD in Organic Chemistry and experience in pharmaceutical secondary packaging materials, while Mr. Valluri is a journalism professional with a Master's in English Literature.
This is a routine governance filing confirming two board appointments already made earlier in 2025. For shareholders, it strengthens board composition with the addition of an independent director, but there is no material change in business operations, ownership, or leadership expected.